Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Soltego
AddedFeb 15, 2024
UpdatedJun 18, 2026
Soltego

Soltego

Series A

SOLTÉGO: A biopharmaceutical innovator leveraging skin pigmentation for therapeutic and aesthetic applications.

HQ
Newport Beach, CA, US
Founded
2017
Overview
Compare
Fundraising
Employees
Website

Founded by experts in dermatology and oncology, Soltego is a biopharmaceutical innovator focused on leveraging skin pigmentation for therapeutic and aesthetic applications. The company's core mission is to harness the biological power of skin pigmentation to develop transformative solutions that protect and enhance skin health. Soltego's product offerings are designed to address both medical and cosmetic needs, targeting a market that spans healthcare providers, dermatologists, and consumers seeking advanced skin care solutions.

Notable figures affiliated with Soltego include leading scientists and medical professionals in the fields of dermatology and oncology. The company has attracted significant interest from investors in the biopharmaceutical sector, underscoring its potential for impactful innovation. Key achievements include pioneering research into skin biology and the development of novel therapies that have garnered attention in both scientific and consumer communities. Overall, Soltego's work promises to make substantial contributions to skin health and aesthetics, positioning it as a leader in its niche market.

Soltego - Similar Companies

OneSkin logo

OneSkin

Siolta Therapeutics logo

Siolta Therapeutics

Soleno Therapeutics logo

Soleno Therapeutics

soleno.life

Naked Biome logo

Naked Biome

Tega Therapeutics logo

Tega Therapeutics

Toragen logo

Toragen

toragen.com

Elgia Therapeutics logo

Elgia Therapeutics

Omni Bioceutical Innovations logo

Omni Bioceutical Innovations

Cage Bio logo

Cage Bio

cagebio.com

Surface Pharmaceuticals logo

Surface Pharmaceuticals

surfacepharma.com

Selva Therapeutics logo

Selva Therapeutics

Cosmederm Bioscience logo

Cosmederm Bioscience

Visiox logo

Visiox

visioxpharma.com

Pelage Pharma logo

Pelage Pharma

pelagepharma.com

Stealth BioTherapeutics logo

Stealth BioTherapeutics

stealthbt.com

Soltego - Quick Facts

Who are Soltego's competitors?

Companies similar to Soltego include OneSkin, Siolta Therapeutics, Soleno Therapeutics and Naked Biome.

When was Soltego founded?

Soltego was founded in 2017.

Where is Soltego's headquarters located?

Soltego's headquarters is located in Newport Beach, CA, US.

When was Soltego's last funding round?

Soltego's most recent funding round was for $6.7M (USD) in April 2019.

How much has Soltego raised to-date?

As of Apr 22, 2019, Soltego has raised a total of $6.7M (USD).

How many employees does Soltego have?

Soltego has 9 employees as of Feb 5, 2024.

Soltego - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Consumers
Main Product
  • Cosmetics
  • Therapeutics
Tags
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified